Antibody Therapeutics for Life

Notices

2019 China BioMed Innovation and Investment Conference
  • Written by PharmAbcine
  • Written date 2019-09-21 13:35:16
  • Inquire 469
Attachments 2019 International Innovative Oncology Companies Roadshow Showcase (0910).pptx

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo,

Chairman and CEO of PharmAbcine and Dr. Hyunsun Park, CBO/COO are attending to "2019 China 

BioMed Innovation and Investment Conference" in Suzhou, China on September 21-23 to have 1:1 

partnering meetings. Dr. Jin-San Yoo will present PharmAbcine R&D progress at "International 

Innovative Oncology Companies Roadshow" on September 22, 2019.




http://2018cbiic.phirda.com/ 


Please check the attached file for details.


List





Prev 2019 Scripps Korea Society Symposium
Next PharmAbcine, 20th EDQM MAB Working Party